Back to search

Article

HGD-derived N-formylkynurenine promotes small cell lung cancer chemoresistance by activating ATL2-mediated endoplasmic reticulum remodelling.

2026-01-22

Abstract excerpt

<title>Abstract</title> <p>Tumour cells often express molecules that drive aberrant metabolism and exhibit distinct metabolic patterns to adapt to chemotherapeutic stress, leading to therapeutic resistance. Here, we report that homogentisate 1,2-dioxygenase (HGD) drives the accumulation of N-formylkynurenine (FK) to promote chemotherapy resistance in small cell lung cancer (SCLC) cells. Transcriptomic and metabol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ab3b2f88-bfe6-5ef6-b219-28f67d34e54a
DOI
10.21203/rs.3.rs-8510398/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HGD-derived N-formylkynurenine promotes small cell lung cancer chemoresistance by activating ATL2-mediated endoplasmic reticulum remodelling.DOI 10.21203/rs.3.rs-8510398/v1
Select a neighboring publication to make it the new centre.